1. Home
  2. /
  3. Leadership
  4. /
  5. Fred Schnell, MD, FACP

Fred Schnell, MD, FACP

Chief Medical Officer

Frederick M. Schnell, MD, FACP brings the physician perspective and practice management experience to his role as Medical Director. Dr. Schnell is helping community oncology practices address the future of oncology payment reform. The rapidly changing landscape of cancer care delivery in the United States demands insight like his to craft the future strategies for community oncology.

Board-certified in internal medicine and medical oncology, Dr. Schnell practiced for 34 years at Central Georgia Cancer Care where he served as CEO. His primary focus areas related to breast and genitourinary cancer.

Dr. Schnell is a past president of both COA and the Georgia Society of Clinical Oncology. He is currently the Medical Director of the Georgia Center for Research and Oncology Education, a prior member of the Board of Directors of the Patient Access Network Foundation and served for eight years as a member of the Board of Directors and the Chief Clinical Officer, Cancer Clinics of Excellence. He was named the Distinguished Cancer Clinician award from the Georgia Cancer Coalition.

Dr. Schnell received his medical degree from Case Western Reserve University. He completed his internship and residency at Emory University Affiliated Hospitals, followed by a fellowship in medical oncology and hematology, also at Emory University. Additionally, he served in the National Health Service Corps, United States Public Health Service.

His academic appointments include Clinical Assistant Professor, Department of Medicine, Mercer University School of Medicine, Macon, GA, and Clinical Assistant Professor of Hematology and Oncology at the Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA.

Dr. Schnell has authored numerous studies and was a recipient of the ASCO Clinical Trials Award (ECOG affiliate), has presented at numerous oncology meetings, and was notably an invited speaker at the Korean Cancer Study Group Meeting.